Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You

Endpoints NewsBiopharma's pay oddities of 2025: Executive perks and eccentricities

FierceBiotechGuardant Health nabs FDA test approval to find patients for Boehringer’s new cancer drug

FierceBiotechIpsen R&D chief on pipeline discipline, partnerships and 2026 milestones

Clinical OMICsOrgans-on-a-Chip Offer “Elegant Solution” to Quandary of Animal Models in Drug Design

PharmaVoiceAstellas taps AI to reshape clinical programs as rising stars emerge

FierceBiotechChutes & Ladders—Perrigo CEO ousted over ‘personal conduct’

LabiotechDIY biology experiments: how far has the rabbit hole gone?

Endpoints NewsWuXi AppTec sues Pentagon in challenge over inclusion on Chinese military list

Endpoints NewsGSK took advantage of ASCO dip to get discount on Nuvalent

Endpoints NewsNovo's M&A leader leaves for Forbion; Perrigo CEO's 'personal conduct' issues led to resignation

Clinical OMICsA Spoonful of Hydrogel Keeps the Medicine in Place

Endpoints NewsSciwind has two Western partners for its obesity drug, but is open to more